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The effect of increasing doses from 1.25 to 10 ng/ml of 
PDGF was tested for chemotactic and mitogenic activity on 
psoriatic fibroblasts cultured from involved and uninvolved 
skin of five patients compared to normal fibroblasts from five 
matched control subjects. 
The chemotactic response of psoriatic fibroblasts from in-
volved skin (p < 0.05) and uninvolved skin (p < 0.005) is 
P soriasis is a common skin disease thought to be princi-pally a disease of the epidermis that causes a disruption in the normal events ofkeratinocyte maturation and prolif-eration [1 - 2]. The changes observed in psoriatic dermis compared to normal dermis include dilated tortuous 
cafi llaries and an infiltration of inflammatory cells. Recent studies 
[3 offer evidence that dermis has a prominant role in the appearance 
of psoriatic lesions: Psoriatic fibroblasts induce the hyperprolifera-
tion of normal keratinocytes in vitro, suggesting that the primary 
defect in psoriatic skin may reside in dermal fibroblasts. It is there-
fore of interest to study the growth properties of psoriatic fibrobl asts 
in culture. 
In this study we have investigated the chemotactic and mitogenic 
response of psoriatic fibroblasts to platelet-derived growth factor 
(PDGF). PDGF is a heat stable basic protein, highly mitogenic 
to"Ward fibroblast growth when added to plasma [4 - 5] and the only 
chemotactic agent among the well-known mitogens of fibroblasts 
such as FGF, EGF, and insulin [6]. PDGF specifically stimulates 
chemotaxis of fibroblasts rather than random motility, as shown by 
checker-board analysis [6]. 
This study demonstrates an increased sensitivity of psoriatic fi -
broblas ts to PDGF compared to normal fibroblasts, which may play 
a role in the vascularization and the inflammatory processes in-
volved in psoriatic dermis. 
MATERIALS AND METHODS 
Reagents Highly purified PDGF was purchased from Collabora-
tive Research (Lexington, MA) and was also generously supplied by 
Dr. G Grotendorst (C harleston, SC). Dulbecco's modified Eagle's 
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significantly enhanced compared to normal fibroblasts. Simi-
larly, POGF in the presence of platelet poor human plasma is 
a more potent mitogenic agent in psoriatic fibroblasts than in 
normal fibrobl asts. This increased sensitivity of psoriatic fi-
broblasts to POGF may be related to the inflammatory and 
vascularization processes involved in psoriatic dermis.] Invest 
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medium (DMEM), glutamine, and trypsin were from Flow labora-
tories (Puteaux, France): fetal calf serum (FCS) was purchased from 
Intenned (Strasbourg, France). Nucleopore filters were from Nu-
cleopore Corporation (Pleasanton, CA). Diff-Quik stain was ob-
tained from Merz+Dade AG (Diidingen, Switzerland). PH] thymi-
din (5 C uries / m mol) was from Amersham (Les Ulis, France) . 
Cells Human fibroblasts were isolated from normal and untreated 
adult patients by enzymatic digestion of small pieces (4 mm) of 
dermis skin biopsies taken from non-Iesional and lesional tissues. 
B iopsy of the non-I esional tissue was taken about 5 cm away from a 
lesional area. The skin fragments were rinsed 2 times with 5 ml of 
warm DMEM containing penicillin (5011/ ml) and streptomycin 
(50 l1/ml). The washed skin samples were minced into small pieces 
and incubated with trypsin (2.5 mg/ml) in 10 ml of DMEM for 
1 h. The trypsinized skin fragments were recovered by low-speed 
centrifugation (1000 rpm for 3 n1.in) and incubated in DMEM con-
taining collagenase (1 mg/ml) for 1 h, followed by an incubation in 
0.5 mg/ml collagenase for 18 h !It 3rc with shaking in a (New 
Brunswick) rotatory incubator. Cells were pelleted by centrifuga-
tion at 400 g for 10 min, then resuspended in 9111.1 of DMEM 
containiJ1g 10% FCS, penicillin (50 U /ml), and streptomycin 
(5011/ ml) and plated onto a 90 mm cell culture dish . Cells were 
grown in a 5% CO2 humidified atmosphere at 37°C and culture 
medium was changed every 3 d. At confluency (2.5 X 106 cells/ 
10 mm dish) cells were removed by trypsin treatment (0.5% trypsin 
and 0.2% EDTA) and 7 X 105 cells were replanted per dish. The 
cel ls were used after their third to sixth passage and always at the 
same density (subconfluent) . 
Chemotaxis Assay As previously described [7 - 8], fibroblasts 
harvested from culture dishes by brief exposure to a solution of 
0.05% trypsin /0.02% EDT A, were suspended in an equal volume 
of DMEM, centrifuged at 1000 rpm for 5 min, and resuspended in 
the same medium at room temperature for 1 h with occasional 
agitation. The cells were then washed twice with serum-free 
DMEM, and suspended in the same medium at a concentration of 
1.5 X 106 ce11s/ml. 
Blind-well modifi ed Boyden chemotaxis chamber and Nucleo-
pore polyca rbonate filters (811m diameter pores) were used to mea-
sure fib roblast chemotaxis. The filters were treated with 1 % gelatin 
as previously described to rwmote fibroblast adherence to their 
upper and lower surfaces [9 . Various concentrations of PDGF di-
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luted in DMEM were placed in the lower chamber at attractant 
(150 ml volume). The upper chamber compartments were loaded 
with 200,u1 of fibroblast suspension (3 X 105 cells). Chemotaxis 
chambers were incubated at 37" C for 150 min in a humidified 
atmosphere containing 5% CO 2 , Filters were then removed from 
the chambers and cel ls were fixed and stained using Diff-Quik stain 
(AMS-France). The number of cells on the lower surface of the filter 
was determined by counting the number of nuclei in 10 field under 
phase contrast microscope. The chemotaxis assay was performed in 
duplicate and repeated at least three times for each fibroblast culture. 
Checkerboard analysis has shown that PDGF has a specific chemo-
tactic effect and did not increase random motility. 
Thymidine Incorporation Mitogenic activity was measured as 
previously described [10 - 11] with the following modifications: 
Fibroblasts were plated in 96 wells microtiter plate at 104 cells/well 
in 0.2 ml DMEM plus 10% FCS. The following day the cells were 
was hed twice with serum-free medium and 0.2 ml serum-free 
DMEM was added for 24 h to reduce the basal rate of [3H] thymi-
dine incorporation. Aliquots of PDGF at various concentrations 
were added and allowed to incubate for 20 h, then cultures were 
incubated for 4 h with 0.2,u Ci / well [3H] thymidine (5Ci/mmol) 
and 5% platelet poor "plasma. Platelet poor plasma was prepared as 
previously described [12] . The cells were harvested by a Cell har-
vester and filterdisc transfer system (Skatron A.B, type 7000). Sam-
ples from triplicate wells were counted in Beckman LS 3801 Scinti-
Iation counter using readysafe as scintillation fluids . The 
experiments were repeated twice. 
Score of the Disease The psoriatic area and severity index (PASI) 
score were done according to Frederiksson and Petersson [13) . Sta-
tistical comparison was done using the student's t test. 
Chemotactic Response of Psoriatic Fibroblasts to PDGF Be-
cause the chemotactic response of cells to PDGF occurs prior to the 
stimulation of DNA synthesis and does not require additional mito-
genic faqor, chemotaxis may serve as a direct measure of the initial 
activity of PDGF. Previous studies have shown that PDGF is a 
chemoattractant for human fibroblasts [6,7] . The present work con-
firms the increased attachment of these cells to a gelatin coated filter 
in the Boyden chamber in the presence of purified PDGF (Fig 1). A 
concentration of 20 ng/ml produced a maximal chemotactic effect 
in both normal and psoriatic cell s. However, fibroblasts established 
from both involved and uninvolved skin of psoriatic subjects had 
significantly increased chemotactic response to PDGF compared to 
normal fibroblasts (respectively, p < 0.05 and p < 0.005 in in-
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Figure 1. Chemotactic response of human fibroblasts to POGF. POGF at 
the concentrations indicated was added to the lower compartment of modi_ 
fied Boyden chamber. The chemotaxis assay was performed as described in 
Methods. Results are expressed as percent of control. The control represents 
the fibrob last migration observed using Oulbecco's medium in the lower 
compartment of modified Boyden chamber. The results are the mean ± 
SEM of determinations in five normal fibroblast cultures (opell sqllares) and in 
psoriatic fibroblast cultures es tablished from involved (filled sqllnres) and 
uninvolved skin (filled circles) of five patients. 
volved and uninvolved skin) . The often observed (Table I), but not 
statistica lly different, elevation of chemotactic response to PDGF in 
fibroblasts from uninvolved skin compared to fibroblasts from in-
volved sk in is of potential interest. 
As shown in Table I, there was no relationship between the sever-
ity of the disease as determined by PASI cutaneous score and the 
maximal chemotactic response to PDGF in psoriatic fibroblasts 
from lesional tissue or from nonlesional tissue. 
Mitogenic Response of Psoriatic Fibroblasts to PDGF In 
order to confirm this increased sensitivity of psoriatic fibroblasts to 
PDGF, the mitogenic effect of this agent was compared between 
psoriatic and normal fibroblasts (Fig 2). PDGF in the presence of 
platelet poor plasma stimulated the incorporation of(3H) thymidine 
in a dose dependent manner in human fibroblasts, but PDGF alone 
ill the absence of plasma had no effect (data not shown) . Psoriatic 
fibroblasts from both involved and uninvolved skin were more sen-
Table I: Age, Individual Values of the Cutaneous Score of the Patients and the C hemotactic Response of the Psoriatic and Normal 
Fibroblasts to 20 ng/ml of PDGP 
Max Chemotactic Response 
Age Cutaneous (nb of ce ll s per filter) 
Cell Patients (Years) Score -POGF +POGF % 
Normal Skin 1 43 159 430 287 
2 31 300 690 230 
3 40 300 720 240 
4 30 450 1350 300 
5 60 300 792 264 
Involved Skin 1 62 23.5 150 495 330 
2 26 11.5 200 720 360 
3 28 21.7 300 900 300 
4 60 6.7 150 690 460 
5 40 12.6 300 1095 365 
Uninvolved Skin 1 62 23.5 200 800 400 
2 26 11.5 300 1230 410 
3 28 21.7 300 1449 483 
4 60 6.7 450 1935 430 
5 40 12.6 150 652 435 
• The number of cells on the lower surface of the filter was determined by coullting the number of nuclei ill 10 field (0.6 mOl ill diameter) under phase contrast microscope. The 
results are the mean of at least three experiments. and arc expressed as the number of cell on the entire filter (45 mOl in diameter). 
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Figure 2. Mitogenic response of human fibroblasts to PDGF. PDGF at the 
concentration indicated was added to serum-deprived fibroblasts for 24 h. 
Then 0.2 ).lCi/well [3H] thymidine and 5% platelet poor human plasma 
were added for the last 4 h. The results are the mean ± SEM of determina-
tions in triplicate in four normal fibroblast cultures (opel! squares) and in 
psoriatic fibroblast cultures established from involved (filled squares) and 
uninvolved skin (filled circles) of four patients. 
sitive to the mitogenic effect of PDGF than normal fibroblasts . 
Again, the major stimulatory effect ofPDGF was observed in fibro-
blasts isolated from uninvolved skin as compared to involved skin. 
DISCUSSION 
Growth properties of psoriatic fibroblasts in culture have long been 
debated. Priest Ley and Adams [14-15] reported an increased pro-
liferation of psoriatic fibroblasts in culture. Moreover, these cells 
presented a partial resistance to the proliferation inhibition activity 
of 1.25 dihydroxy vitamin D [16]. We have recently shown a defi-
ciency in cAMP dependent-protein kinase in psoriatic fibroblasts 
[17 -18], which may be related to the partial resistance of these cells 
to the growth-inhibitory effect of 8-bromo cAMP [19] . In this 
study, we demonstrate that psoriatic fibroblasts are more sensitive 
than normal fibroblasts to the action of the growth factor PDGF. 
PDGF is a cationic glycoprotein of approximately 30 KD. This 
factor is stored in the granules of platelets and released during the 
platelet-release reaction [20]. PDGF is also secreted by monocytes, 
macrophages, endothelial cells, and transformed cells [21-23] . 
PDGF interacts with reponsive celJs by rapidly inducing the turn-
over of phosphatidylinositol, the release of free arachidonic acid, 
and the formation of eicosanoids, particularly prostaglandins PGE 1 
and PGE2 [24] . The early release of free arachidonic acid may induce 
the activation of phospholipase A2 [25]. 
It is of interest to note that increased transformation of arachi-
donic acid [26] and increased activity of phospholipase A2 [27] have 
been described, respectively, in psoriatic dermis and epidermis. 
These abriormalities have been found to be more clearly expressed 
in uninvolved dermis. Our study suggests that the increased sensi-
tivity of psoriatic fibroblasts to PDGF, maximal in fibroblasts from 
uninvolved skin, may explain these previous findings . 
In addition, human dermal fibroblasts stimulated with PDGF 
show an increase in collagenase activity [28]. Because this enzym.e 
activity is the rate-limiting step ,in initiation of collagen degrada-
tion, it may playa role in preparing the extracellular milieu for 
mitosis and cell movement by changing the extracellular matrix. 
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These cellular and extraceJJular events, stimulated by PDGF, are 
involved in the inflammatory process observed in psoriatic dermis. 
In conclusion, our data further support the hypothesis that the 
dermis may have a predominant role in the pathology of psoriasis. 
Fibroblasts in culture from involved and uninvolved skin have com-
parable characteristics. Their increased sensitivity to the chemotac-
tic and mitogenic effects of PDGF may playa role in the inflamma-
tory process and in the vascularization defect observed in psoriasis. 
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